Document is current
Any future updates will be listed below
-
Authors
Hollitt, Georgina L
Hassall, Mark M
Siggs, Owen M
Craig, Jamie E
Souzeau, Emmanuelle
-
Funding
Funding for this research was provided by:
Snow Fellowship
National Health and Medical Research Council (GNT1154824, GNT2016545)
BrightFocus Foundation (G2022002F)
- License Information
-
More Information
Article History
Received: 25 September 2024
Accepted: 23 December 2024
First Online: 30 January 2025
Declarations
:
: This study was approved by the Southern Adelaide Clinical Human Research Ethics Committee (SAC HREC, ethics approval 2020/HRE00968). All participants provided informed written consent.
: Not applicable.
: JEC is a co-inventor on a patent application for the use of genetic risk scores in predicting glaucoma risk. OMS, MMH and JEC hold equity in Seonix Pty Ltd, which has commercialised a clinical PRS test for glaucoma. GLH, ES: None.
